Denver Company Applies For Pot Patent For Treatments

October 31st, 2014 by The General No comments »
United Cannabis Corp. had filed for a patent on its cannabinoids with the U.S. Patent and Trademark Office, with the hopes of expanding its medical marijuana capabilities. The Denver-based company wants to offer its cannabinoids in pill form for the treatment of various ailments, including post traumatic stress disorder and neuropathy, said Chad Ruby, COO of United Cannabis.

United Cannabis (OTCBB: CNAB) uses a proprietary strain of marijuana, Prana Bio Nutrient Medicinals, to treat very ill patients, Ruby said. In preclinical and clinical studies, researchers from United Cannabis developed medications based on delivering cannabinoids at specific ratios and timing that helps the body reestablish homeostasis, or the state in which variables in the body are stable and relatively constant.

"We've been able to exploit this effect and have developed treatment programs and protocols to treat a wide variety of disorders," said Tony Verzura, chief technology officer for United Cannabis. In the future, the company hopes to expand on these findings to try and reverse the effects of the certain disorder.

"Our focus is not on the treatment of symptoms of disease, but rather on reversing the underlying pathology that drives and contributes to specific disorders. These patents stem from that unique approach and the success we have seen for patients using our Prana products and ACT Now Program," Verzura said. The ACT Now Program refers to United Cannabis' Advanced Cannabinoid Therapy software, a cloud-based electronic health record software used by physicians to handle scheduling, billing and other necessary information. The software is compliant with the Health Insurance Portability and Accountability Act and allows patients access to all their health records, including cannabinoid-based treatment programs using Prana Bio Nutrient Medicinals.

United Cannabis will take its product through clinical trial steps during the patenting process. This includes phase 1 safety trials and phase 2 and 3 efficacy trials, Verzura said. United Cannabis this week also announced that it has signed an exclusive, 10-year agreement with a Dutch company to distribute its products. Amsterdam-based DNA Genetics has researched and developed hundreds of cannabis strains, according to United Cannabis. Under the agreement, United Cannabis will serve as the distributor for DNA Genetics in Colorado and will have first right of refusal in all states where DNA Genetics become licensed.

The companies will work together to develop a regional breeding program to develop plants in each of the geographic areas where United Cannabis or its affiliates grow, refine or dispense pot. This will allow both companies to comply with regulations that prohibit the sale or transfer of any cannabis plant materials between markets, United Cannabis said.

News Moderator - The General @ 420 MAGAZINE ®
Author: Molly Armbrister
Contact: Contact Us
Website: Denver company applies for pot patent for treatments - Denver Business Journal

Marijuana-infused candy found in Prince George’s County

October 31st, 2014 by marijuana - Yahoo! News Search Results No comments »
Police are warning parents to pay attention to what their kids bring home on Halloween.

Don’t Worry, Government Weed Will Probably Remain Legal In Uruguay After All

October 31st, 2014 by The General No comments »
In the run up to elections over the weekend, it looked as though the opposition may gain enough momentum to throw cold water on Uruguay’s trailblazing legalization of the marijuana trade. But after a better-than-expected performance for the governing Broad Front coalition in Sunday’s congressional elections, it looks highly unlikely that the law will be dismantled. The leading opposition candidate in the four-way race, Luis Lacalle Pou, told Reuters this month that if elected he would try to repeal a law passed by the current government that legalized the limited possession and sale of marijuana for recreational use to licensed permanent residents. Polls showing gains for the opposition made Lacalle’s campaign pledge look like a real possibility.

In the end, polls that had placed Vásquez’s support around 42 percent misgauged voter sentiment. The Broad Front presidential candidate, former President Tabaré Vásquez, won 48 percent of the vote, surpassing expectations and nearly obviating the need for a runoff election. Lacalle trailed distantly with 31 percent, casting doubts on his ability to win the second-round election slated for Nov. 30. The leftwing Broad Front, which spearheaded the weed law passed last year, also retained its majority in the country’s lower house by one seat, making it difficult for the opposition to repeal the weed law even if it won the presidency.

If Vásquez wins the presidency in next month’s runoff, the Broad Front will also hold the deciding vote in the country’s Senate. The marijuana law isn’t popular in Uruguay, where polls show two in three people oppose it. But President José Mujica has defended the law, saying it allows the government to wrest power away from organized crime. Mujica has encouraged other countries, including the United States, to follow Uruguay's example.

News Moderator - The General @ 420 MAGAZINE ®
Author: Roque Planas
Contact: Contact Us
Website: Don't Worry, Government Weed Will Probably Remain Legal In Uruguay After All

Federal Evidentiary Hearing Regarding The Constitutionality Of Cannabis Prohibition Concludes

October 31st, 2014 by Paul Armentano, NORML Deputy Director No comments »

United States District Judge Kimberly Mueller heard testimony over the course of the past five days in regard to the constitutionality of the federal statute designating marijuana as a Schedule I Controlled Substance. At issue in this evidentiary hearing is whether the scientific literature provides a rational basis for the federal classification of the plant as a substance with “a high potential for abuse,” “no currently accepted medical use,” and a “lack of accepted safety” for use under medical supervision.

The federal government’s position was articulated in testimony provided by Dr. Bertha Madras, Professor of Psychobiology at Harvard Medical School and the former Deputy Director for Demand Reduction for the White House Office of National Drug Control Policy under President George W. Bush.

Expert witnesses for the defense who testified at the hearing were Dr. Carl Hart, Associate Professor of Psychology in the Department of Psychiatry and Psychology at Columbia University in New York City, retired physician Phillip Denny, Dr. Greg Carter, Medical Director of St. Luke’s Rehabilitation Institute in Spokane, Washington, and marijuana cultivation expert and archivist Chris Conrad.

Defense counsel for the litigants were NORML Legal Committee members Zenia Gilg of San Francisco and Heather Burke of Nevada City, CA. I assisted attorneys Gilg and Burke as a consultant in the case prior to the hearing and as their principle investigator during the hearing — a point that the federal government’s attorneys insisted on making public on Wednesday by insisting the judge recognize that: “Defense counsels’ investigator is the Deputy Director of NORML; he’s not some ordinary investigator.”

Representatives from California NORML as well as writer Jeremy Daw of TheLeafOnline were in attendance during the hearing and provide day-by-day coverage of events on their respective websites and at the links below. Dr. Madras was cross-examined both Wednesday afternoon and Thursday morning.







A ruling by Judge Mueller is not anticipated until after the first of the year.

Marijuana to wages: What's at stake this election

October 31st, 2014 by marijuana - Yahoo! News Search Results No comments »
With the midterm elections Tuesday, businesses in select states have much at stake with ballot outcomes that could impact marijuana use, minimum wages and Medicaid.

Denmark Funds Medicinal Cannabis Research

October 31st, 2014 by The General No comments »
Despite numerous pushes by Copenhagen’s mayor Frank Jensen to legalise cannabis in the capital and the booming business in Christiania’s cannabis market, Denmark has taken an official hardline stance on cannabis for both recreational and medicinal use. But signs have been emerging over the past few years that the nation may be prepared to adjust its stance on cannabis.

In addition to Jensen’s high-profile but ultimately failed attempts to get cannabis legalised in Copenhagen on a trial basis, politicians from both sides of the political aisle have begun signalling a willingness to look at Denmark’s drug laws. Following a World Health Organization report in July that called for the decriminalisation of all drugs, parties ranging from the ruling Social Democrats to the libertarian Liberal Alliance and the left-wing Socialist People’s Party said that it is high time to reconsider Denmark’s official position on drugs.

Thursday’s agreement on the distribution of state funds is another sign that the tide may be slowly turning, at least when it comes to medicinal cannabis. A research agreement that distributes 857 million kroner ($145 million) to a wide variety of projects has earmarked money for studying the benefits of medicinal cannabis for the first time. “A minimum of 35 million kroner [$5.9 million, ed.] will be allotted for health, quality of life and clinical research that can contribute to a better understanding of illness and prevention and more accurate treatments to benefit patients. In that context, it can include research projects on pain relief, including the use of medicinal cannabis,” the agreement reads.

The allocation of funds to medicinal cannabis was praised by both the Liberal Alliance (LA) and the left-wing Red-Green Alliance (Enhedslisten). “The new research agreement includes research into medicinal cannabis. About time!” LA party leader Anders Samuelsen wrote on Facebook. “I am very pleased that we were able to secure resources for the research of medicinal cannabis. There is a lot that indicates that cannabis can help patients with sclerosis and epilepsy. It’s important that we have more knowledge that can benefit the patients,” Enhedslisten’s Rosa Lund said in a statement. The 857 million kroner research agreement also included a large focus on psychological research, funds for researching food production and education and a study into the civil use of drones.

News Moderator - The General @ 420 MAGAZINE ®
Author: Coleen Whitfield-Flickr
Contact: Contact Us
Website: Denmark funds medicinal cannabis research - The Local

Illinois – Medical Pot Rollout Slowed By Security Snags

October 31st, 2014 by The General No comments »
Selling pot was a lot simpler back when all you needed was a good scale and an ample supply of Baggies. Security measures under the rigorous Illinois medical marijuana law could push back the date when authorized patients can begin purchasing their allotted 2.5 ounces every two weeks, although the state is still saying it will be available early next year. Implementing the new law was not expected to be easy, with the state taking almost a year to write regulations and start issuing licenses to patients. Applications from growers and sellers are under review, and the first licenses are expected by the end of the year. However, a recent procurement of tamper-proof identification cards was canceled and put out for bid again on Oct. 28 because no bidders met the strict security requirements the first time.

Police & Sheriff's Press Inc., a firm in Vidalia, Ga., that makes the ID cards that allow air marshals to carry guns on planes, for example, didn't bid on the contract, said Glenn Raiford, the company's owner and president. The specifications "didn't fall into the normal and customary card issuance procedures,” he said. “The requirements were so restrictive that it wasn't conducive for us to bid.” Specifically, the state wants the card vendor to have the security certification of a MasterCard or Visa card issuer, which isn't cheap or easy to obtain. Mr. Raiford said it would cost $500,000 a year to obtain that certification, which makes sense for a credit card issuer making millions of cards, but not for the 100,000 cards the state is ordering. “Thanks but no thanks,” he said. With a request for bids on the ID cards going out again almost immediately, the state doesn't expect startup to be delayed.

“We think a number of potential vendors were not aware of the bid and we think now there is more awareness of the invitation for bid,” said a spokeswoman for the Illinois Medical Cannabis program in an email. "We anticipate awarding licenses by the end of the year, with businesses opening and product available the first part of next year.”

However, another recent request for proposals (RFP) on comprehensive inventory tracking software, monitoring from “seed to sale,” said the state's target date for the system to “go live” is not until “on or before April 2015.” “If they're not going to allow production until April, you're talking well into midsummer before product is available,” said Dan Linn, executive director of the Illinois chapter of the National Organization for the Reform of Marijuana Laws, noting that it takes about four months for a crop to mature.

It may be necessary to monitor the start of production by other means until the system is operational. “Having the entire program operational before April 2015 is still possible,” said the spokeswoman for the Illinois medical cannabis program. “Inventory tracking will occur using a variety of methods and technology platforms, but cultivation centers will be permitted to start growing medical cannabis following issuance of a license by the Department of Agriculture. There is a pending RFP for an inventory tracking system, but generally we will ensure that we have sufficient inventory tracking systems in place so there is no interruption of the implementation of the pilot program.”

News Moderator - The General @ 420 MAGAZINE ®
Author: Paul Merrion
Contact: Contact Us
Website: Medical-pot-rollout-slowed-by-security-snags

NORML PAC Endorses Representative Grayson for Congress

October 31st, 2014 by Erik Altieri, NORML Communications Director No comments »

NORML PAC is endorsing Representative Alan Grayson in his campaign to be re-elected to the US Congress representing Florida’s 9th Congressional District.

“Representative Grayson is a proven leader with a track record of tenaciously advocating for causes he believes in and building the necessary coalitions required to see them approved,” stated NORML PAC Manager Erik Altieri, “In 2015, Rep. Grayson wants to be a champion for marijuana law reform at the national level and we’d strongly encourage voters in his district to vote him in for another term.”

This year, Rep. Grayson joined many of his colleagues in the House in voting in favor of amendments that would have prevented the Department of Justice and DEA from expending funds interfering with state medical marijuana programs and help clear the way for marijuana businesses to have access to banking and credit card services.

You can learn more about his campaign, including how to donate and volunteer, on his website or Facebook page.

Marijuana could be spoiler in Fla. governor's race

October 31st, 2014 by marijuana - Yahoo! News Search Results No comments »
WEST PALM BEACH, Fla. (AP) — Florida's race for governor has focused on the candidates' integrity and their credit or blame for the economy.

Canada Will Tax Marijuana Just Like Tylenol

October 31st, 2014 by marijuana - Yahoo! News Search Results No comments »
Cannabis Investment Expert Joins Supreme Pharmaceuticals